Urania Georgopoulou

Dr. Urania Georgopoulou

Hellenic Pasteur Institute, Molecular Virol Laboratory, Vas Sofias 127 Ave, Athens 11521, Greece
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2014 in Virulence
Verified
Journal Article
Open access
Urania GeorgopoulouUrania Georgopoulou
Urania Georgopoulou
ADAlexios Dimitriadis
Alexios Dimitriadis
PFPelagia Foka
Pelagia Foka
EKEirini Karamichali
Eirini Karamichali
AMAvgi Mamalaki
Avgi Mamalaki
An estimated 30–40% of patients with chronic hepatitis C have elevated serum iron, transferrin saturation, and ferritin levels. Clinical data suggest that iron is a co-morbidity factor for disease progression following HCV infection. Iron is essential for a number of fundamental metabolic processes in cells and organisms. Mammalian iron homeostasis is tightly regulated and this is maintained through the coordinated action of sensory and regulatory networks that modulate the expression of iron-related proteins at the transcriptional and/or posttranscriptional levels. Disturbances of iron homeostasis have been implicated in infectious disease pathogenesis. Viruses, similarly to other pathogens, can escape recognition by the immune system, but they need iron from their host to grow and spread. Hepcidin is a 25-aa peptide, present in human serum and urine and represents the key peptide hormone, which modulates iron homeostasis in the body. It is synthesized predominantly by hepatocytes and its mature form is ...

8 April 2016 in Virulence
Verified
Journal Article
Open access
PFPelagia Foka
Pelagia Foka
ADAlexios Dimitriadis
Alexios Dimitriadis
EKEirini Karamichali
Eirini Karamichali
EKEleni Kyratzopoulou
Eleni Kyratzopoulou
DGDionyssios Giannimaras
Dionyssios Giannimaras
Urania GeorgopoulouUrania Georgopoulou
Urania Georgopoulou
Mechanisms that favor Hepatitis C virus (HCV) persistence over clearance are unclear, but involve defective innate immunity. Chronic infection is characterized by hepatic iron overload, hyperferraemia and hyperferittinaemia. Hepcidin modulates iron egress via ferroportin and its storage in ferritin. Chronic HCV patients have decreased hepcidin, while HCV replication is modified by HAMP silencing. We aimed to investigate interactions between HCV and hepcidin, during acute and chronic disease, and putative alterations in cellular iron homeostasis that enhance HCV propagation and promote viral persistence. Thus, we used HCV JFH-1-infected co-cultures of Huh7.5 hepatoma and THP-1 macrophage cells, HCV patients’ sera and Huh7 hepcidin-expressing cells transfected with HCV replicons. Hepcidin levels were elevated in acutely infected patients, but correlated with viral load in chronic patients. HAMP expression was up-regulated early in HCV infection in vitro, with corresponding changes in ferritin and FPN. Hepcidin overexpression enhanced both viral translation and replication. In HCV-infected co-cultures, we observed increased hepcidin, reduced hepatoma ferritin and a concurrent rise in macrophaghic ferritin over time. Altered iron levels complemented amplified replication in hepatoma cells and one replication round in macrophages. Iron-loading of macrophages led to enhancement of hepatic HCV replication through reversed ferritin “flow.” Viral transmissibility from infected macrophages to naïve hepatoma cells was induced by iron. We propose that HCV control over iron occurs both by intracellular iron sequestration, through hepcidin, and intercellular iron mobilisation via ferritin, as means toward enhanced replication. Persistence could be achieved through HCV-induced changes in macrophagic iron that enhances viral replication in these cells.

10 April 2014 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
PFPelagia Foka
Pelagia Foka
ADAlexios Dimitriadis
Alexios Dimitriadis
EKEleni Kyratzopoulou
Eleni Kyratzopoulou
DGDionysios A. Giannimaras
Dionysios A. Giannimaras
SSStefania Sarno
Stefania Sarno
AMAvgi Mamalaki
Avgi Mamalaki

1 April 2010 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
KKKonstantina Katsarou
Konstantina Katsarou
Alexandros LavdasAlexandros Lavdas
Alexandros Lavdas
PTPanagiota Tsitoura
Panagiota Tsitoura
ESElisavet Serti
Elisavet Serti
PMPanagiotis Markoulatos
Panagiotis Markoulatos
Urania GeorgopoulouUrania Georgopoulou
Urania Georgopoulou

31 July 2014 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
TSThomas Simos
Thomas Simos
Urania GeorgopoulouUrania Georgopoulou
Urania Georgopoulou
GTGeorge Thyphronitis
George Thyphronitis
John KoskinasJohn Koskinas
John Koskinas
Costas PapaloukasCostas Papaloukas
Costas Papaloukas
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are the major causes of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC). The resolution or chronicity of acute infection is dependent on a complex interplay between virus and innate/adaptive immunity. The mechanisms that lead a significant proportion of patients to more severe liver disease are not clearly defined and involve virus induced host gene/protein alterations. The utilization of protein interaction networks (PINs) is expected to identify novel aspects of the disease concerning the patients' immune response to virus as well as the main pathways that are involved in the development of fibrosis and HCC. In this study, we designed several PINs for HBV and HCV and employed topological, modular, and functional analysis techniques in order to determine significant network nodes that correspond to prominent candidate biomarkers. The networks were built using data from various interaction databases. When the overall PINs of HBV and HCV were compared, 48 nodes were found in common. The implementation of a statistical ranking procedure indicated that three of them are of higher importance.

Verified
Journal Article
Open access
PDF file
EKEirini Karamichali
Eirini Karamichali
Peli FokaPeli Foka
Peli Foka
GPGeorgia Papadopoulou
Georgia Papadopoulou
DLDomniki Loukaki-Gkountara
Domniki Loukaki-Gkountara
KAKonstantina Andresaki
Konstantina Andresaki
Urania GeorgopoulouUrania Georgopoulou
Urania Georgopoulou
The development of smart immune evasion mechanisms is crucial for the establishment of acute and chronic viral hepatitis. Hepatitis is a major health problem worldwide arising from different causes, such as pathogens, metabolic disorders, and xenotoxins, with the five hepatitis viruses A, B, C, D, and E (HAV, HBV, HCV, HDV, and HEV) representing the majority of the cases. Most of the hepatitis viruses are considered enveloped. Recently, it was reported that the non-enveloped HAV and HEV are, in reality, quasi-enveloped viruses exploiting exosomal-like biogenesis mechanisms for budding. Regardless, all hepatitis viruses use exosomes to egress, regulate, and eventually escape from the host immune system, revealing another key function of exosomes apart from their recognised role in intercellular communication. This review will discuss how the hepatitis viruses exploit exosome biogenesis and transport capacity to establish successful infection and spread. Then, we will outline the contribution of exosomes in viral persistence and liver disease progression.